论文部分内容阅读
目的探讨乳糖酸阿奇霉素治疗小儿支气管肺炎的临床效果。方法选取民权县中医院2013年3月至2015年3月收治的60例支气管肺炎患儿,随机分为对照组和观察组,各30例。对照组给予阿莫西林克拉维酸钾治疗,观察组给予乳糖酸阿奇霉素治疗,对比分析两组临床疗效及不良反应发生情况。结果观察组治疗总有效率为93.33%,明显高于对照组73.33%,差异有统计学意义(P<0.05);对照组不良反应发生率为23.33%,明显高于观察组10.00%,差异有统计学意义(P<0.05)。结论乳糖酸阿奇霉素治疗小儿支气管肺炎效果较好,可快速改善患儿临床症状,安全性高,值得推广。
Objective To investigate the clinical effect of azithromycin lactobionate on bronchial pneumonia in children. Methods Sixty children with bronchopneumonia treated in Minquan County Chinese Medicine Hospital from March 2013 to March 2015 were randomly divided into control group and observation group, with 30 cases in each group. The control group was treated with amoxicillin and clavulanate potassium. The observation group was given azithromycin lactobionate. The clinical efficacy and adverse reactions were compared between the two groups. Results The total effective rate of the observation group was 93.33%, which was significantly higher than that of the control group (73.33%), the difference was statistically significant (P <0.05); the incidence of adverse reactions in the control group was 23.33%, significantly higher than that of the observation group 10.00% Statistical significance (P <0.05). Conclusion Azithromycin lactobionate treatment of bronchial pneumonia in children is better, can quickly improve the clinical symptoms of children with high safety, it is worth promoting.